new_logo_anew_logo_anew_logo_anew_logo_a
  • Company
    • Our Mission
    • Leadership
    • Pipeline
    • Partnership
  • Our Technology
    • GTailor
    • Quantum Nufect
    • Quantum pBac
    • iCellar
  • Investors
    • Press Releases
    • Events & Presentations
    • Publications
  • Careers
  • Contact Us

Publication

Steps toward targeted insertional mutagenesis with class II transposable elements

DOI: 10.1007/978-1-59745-232-8_10
Journal: Methods in Molecule Biology

Transposon-based Vector Systems for Gene Therapy Clinical Trials: Challenges and Considerations

DOI: N/A
Journal: Chang Gung Med J


piggyBac is a flexible and highly active transposon as compared to Sleeping Beauty, Tol2, and Mos1 in mammalian cells

DOI: https://doi.org/10.1073/pnas.0606979103
Journal: PNAS

The piggyBac transposon holds promise for human gene therapy

DOI: https://doi.org/10.1073/pnas.0607282103
Journal: PNAS


Genome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy

DOI: 10.1186/1472-6750-11-28
Journal: BMC Biotechnology

A versatile, highly efficient, and potentially safer piggyBac transposon system for mammalian genome manipulations

DOI: https://doi.org/10.1096/fj.12-223586
The FASEB Journal

Company

  • Our Mission
  • Leadership
  • Pipeline
  • Partnership

Our Technology

  • GTailor
  • Quantum Nufect
  • Quantum pBac
  • iCellar

Investors

  • Press Release
  • Events & Presentation
  • Publication

Careers

Contact Us

© 2020 GenomeFrontier Therapeutics, Inc. All Rights Reserved.